ACLS Stock Outlook 2026: Axcelis, Ion Implantation, and the China Risk Trade-Off
Axcelis Technologies (ACLS) 2026 stock analysis: the Purion ion implantation franchise, power-semiconductor (SiC) and image-sensor demand, mature-node strength, recurring service revenue, and the China exposure, EV-demand, and equipment-cycle risks investors must weigh.